What Role Does Keytruda Play in Modern Cancer Treatment Strategies?
Valued at USD 30.45 billion in 2025, the Keytruda market is projected to reach USD 33.26 billion in 2026 and USD 68.75 billion by 2034, growing at a CAGR of 9.5% during the forecast period 2026–2034. Leading companies include Merck & Co., Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, AstraZeneca plc, Pfizer Inc., Novartis AG, Sanofi S.A., Johnson & Johnson, GSK plc,...
0 Comments 0 Shares 238 Views 0 Reviews